Form 6B ORDR LAZARD ASSET MANAGEMENT
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zymeworks to acquire Theravance Biopharma for $17 per share
- Zymeworks to buy Theravance Biopharma for $17 per share
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
